Work

Discovery and validation of the nuclear export protein CRM1 (XPO1) as a new target for the treatment of renal cell carcinoma (RCC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.411

Authors: Hiromi Inoue Wettersten, Michael Kauffman, Sharon Shacham, Yosef Landesman, Joy Yang, Christopher Evans, Robert Weiss

Institutions: University of California, Davis, Karyopharm Therapeutics (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590172458

Cites:

Cited by:

Related to: 10